Exploring the role of mesoporous silica nanoparticle in the development of novel drug delivery systems
- PMID: 33604837
- DOI: 10.1007/s13346-021-00935-4
Exploring the role of mesoporous silica nanoparticle in the development of novel drug delivery systems
Abstract
The biocompatible nature of mesoporous silica nanoparticles (MSN) attracted researchers' attention to deliver therapeutic agents in the treatment of various diseases, where their porous nature, high drug loading efficiency, and suitability to functionalize with a specific ligand of MSN helped to obtain the desired outcome. The application of MSN has been extended to deliver small chemicals to large-sized peptides or proteins to fight against complex diseases. Recently, formulation researches with MSN have been progressed for various non-conventional drug delivery systems, including liposome, microsphere, oro-dispersible film, 3D-printed formulation, and microneedle. Low bulk density, retaining mesoporous structure during downstream processing, and lack of sufficient in vivo studies are some of the important issues towards the success of mesoporous silica-based advanced drug delivery systems. The present review has aimed to evaluate the application of MSN in advanced drug delivery systems to critically analyze the role of MSN in the respective formulation over other functionalized polymers. Finally, an outlook on the future direction of MSN-based advanced drug delivery systems has been drawn against the existing challenges with this platform.
Keywords: 3D printing; Advanced drug delivery system; Hydrogel; Mesoporous silica nanoparticles; Microneedle; Microsphere.
© 2021. Controlled Release Society.
Similar articles
-
Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.Curr Drug Deliv. 2023;20(9):1337-1350. doi: 10.2174/1567201819666220616121602. Curr Drug Deliv. 2023. PMID: 35713141
-
Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.Adv Drug Deliv Rev. 2008 Aug 17;60(11):1278-1288. doi: 10.1016/j.addr.2008.03.012. Epub 2008 Apr 10. Adv Drug Deliv Rev. 2008. PMID: 18514969 Review.
-
A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.Int J Nanomedicine. 2019 May 31;14:4029-4044. doi: 10.2147/IJN.S201688. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31213813 Free PMC article.
-
Charge-Selective Delivery of Proteins Using Mesoporous Silica Nanoparticles Fused with Lipid Bilayers.ACS Appl Mater Interfaces. 2019 Jan 30;11(4):3645-3653. doi: 10.1021/acsami.8b15390. Epub 2019 Jan 16. ACS Appl Mater Interfaces. 2019. PMID: 30609348
-
Mesoporous silica nanoparticles in drug delivery and biomedical applications.Nanomedicine. 2015 Feb;11(2):313-27. doi: 10.1016/j.nano.2014.09.014. Epub 2014 Nov 13. Nanomedicine. 2015. PMID: 25461284 Review.
Cited by
-
The inhibitory effect of human umbilical cord mesenchymal stem cells expressing anti-HAAH scFv-sTRAIL fusion protein on glioma.Front Bioeng Biotechnol. 2022 Nov 8;10:997799. doi: 10.3389/fbioe.2022.997799. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36425649 Free PMC article.
-
Increasing Bioavailability of Trans-Ferulic Acid by Encapsulation in Functionalized Mesoporous Silica.Pharmaceutics. 2023 Feb 16;15(2):660. doi: 10.3390/pharmaceutics15020660. Pharmaceutics. 2023. PMID: 36839982 Free PMC article.
-
Development of Essential Oil Delivery Systems by 'Click Chemistry' Methods: Possible Ways to Manage Duchenne Muscular Dystrophy.Materials (Basel). 2023 Oct 2;16(19):6537. doi: 10.3390/ma16196537. Materials (Basel). 2023. PMID: 37834674 Free PMC article. Review.
-
Mesoporous Materials as Elements of Modern Drug Delivery Systems for Anti-Inflammatory Agents: A Review of Recent Achievements.Pharmaceutics. 2022 Jul 25;14(8):1542. doi: 10.3390/pharmaceutics14081542. Pharmaceutics. 2022. PMID: 35893798 Free PMC article. Review.
-
Green Chemistry Principles for Nano- and Micro-Sized Hydrogel Synthesis.Molecules. 2023 Feb 23;28(5):2107. doi: 10.3390/molecules28052107. Molecules. 2023. PMID: 36903352 Free PMC article. Review.
References
-
- Zahedi P, Yoganathan R, Piquette-Miller M, Allen C. Recent advances in drug delivery strategies for treatment of ovarian cancer. Expert Opin Drug Deliv. Taylor & Francis. 2012;9:567–83.
-
- Slowing II, Vivero-Escoto JL, Wu CW, Lin VSY. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev Elsevier. 2008;60:1278–88. - DOI
-
- Mai WX, Meng H. Mesoporous silica nanoparticles: a multifunctional nano therapeutic system. Integr Biol (United Kingdom). Royal Society of Chemistry. 2013;5:19–28.
-
- Choudhury H, Maheshwari R, Pandey M, Tekade M, Gorain B, Tekade RK. Advanced nanoscale carrier-based approaches to overcome biopharmaceutical issues associated with anticancer drug ‘Etoposide.’ Mater Sci Eng C. Elsevier. 2020;106:110275.
-
- Kanaujia P, Poovizhi P, Ng WK, Tan RBH. Amorphous formulations for dissolution and bioavailability enhancement of poorly soluble APIs. Powder Technol. 2015.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous